Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma.
| Autor: | May, RD1, Monk, PD2, Cohen, ES1, Manuel, D1, Dempsey, F3, Davis, NHE1, Dodd, AJ1, Corkill, DJ1, Woods, J1, Joberty-Candotti, C1, Conroy, LA1, Koentgen, F4, Martin, EC5, Wilson, R6, Brennan, N7, Powell, J8, Anderson, IK1 |
|---|---|
| Zdroj: | British Journal of Pharmacology. May2012, Vol. 166 Issue 1, p177-193. 17p. 6 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|